Top compounds associated with response to TMPO


Feature Type Standardized
Nominal ANOVA
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.19 4e-09
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 6e-09
mRNA manumycin A CTRPv2 pan-cancer AAC 0.19 8e-09
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.2 8e-09
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.18 9e-09
mRNA GW843682X CTRPv2 pan-cancer AAC 0.21 9e-09
mRNA Irinotecan CCLE pan-cancer AAC 0.32 1e-08
mRNA paclitaxel CCLE pan-cancer AAC 0.27 1e-08
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.19 2e-08
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.21 2e-08
Download CSV